
Which Treatments Lead Neuropathic Pain Care?
TOPLINE: A meta-analysis of 313 trials found that tricyclic antidepressants (TCAs), serotonin and norepinephrine reuptake inhibitors (SNRIs), and alpha-2-delta ligands offered modest efficacy for neuropathic pain and were recommended as first-line …